Merck

Nanotherapeutics shielded with a pH responsive polymeric layer.

Physiological research (2015-10-09)
L Kostka, V Šubr, R Laga, P Chytil, K Ulbrich, L W Seymour, T Etrych
ABSTRACT

Efficient intravenous delivery is the greatest single hurdle, with most nanotherapeutics frequently found to be unstable in the harsh conditions of the bloodstream. In the case of nanotherapeutics for gene delivery, viral vectors are often avidly recognized by both the innate and the adaptive immune systems. So, most modern delivery systems have benefited from being coated with hydrophilic polymers. Self-assembling delivery systems can achieve both steric and lateral stabilization following surface coating, endowing them with much improved systemic circulation properties and better access to disseminated targets; similarly, gene delivery viral vectors can be 'stealthed' and their physical properties modulated by surface coating. Polymers that start degrading under acidic conditions are increasingly investigated as a pathway to trigger the release of drugs or genes once the carrier reaches a slightly acidic tumor environment or after the carrier has been taken up by cells, resulting in the localization of the polymer in acidic endosomes and lysosomes. Advances in the design of acid-degradable drug and gene delivery systems have been focused and discussed in this article with stress placed on HPMA-based copolymers. We designed a system that is able to "throw away" the polymer coat after successful transport of the vector into a target cell. Initial biological studies were performed and it was demonstrated that this principle is applicable for real adenoviral vectors. It was shown that the transfection ability of coated virus at pH 7.4 is 75 times lower then transfection at pH 5.4.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N,N-二甲基甲酰胺, anhydrous, 99.8%
Sigma-Aldrich
四氢呋喃, anhydrous, ≥99.9%, inhibitor-free
Sigma-Aldrich
二氯甲烷, anhydrous, ≥99.8%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
四氢呋喃, anhydrous, contains 250 ppm BHT as inhibitor, ≥99.9%
Sigma-Aldrich
三氟乙酸, ReagentPlus®, 99%
Sigma-Aldrich
羟乙基哌嗪乙硫磺酸, ≥99.5% (titration)
Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
三乙基胺, ≥99.5%
Sigma-Aldrich
盐酸, ACS reagent, 37%
Sigma-Aldrich
羟乙基哌嗪乙硫磺酸, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
N,N-二甲基甲酰胺, ACS reagent, ≥99.8%
Sigma-Aldrich
二氯甲烷, contains 40-150 ppm amylene as stabilizer, ACS reagent, ≥99.5%
Sigma-Aldrich
三乙基胺, ≥99%
Sigma-Aldrich
氯化氢 溶液, 4.0 M in dioxane
Sigma-Aldrich
四氢呋喃, contains 250 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
盐酸, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
盐酸 溶液, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
三乙基胺, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
2,2′-偶氮(2-甲基丙腈), 98%
Sigma-Aldrich
三氟乙酸, puriss. p.a., suitable for HPLC, ≥99.0% (GC)
Sigma-Aldrich
盐酸, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., fuming, ≥37%, APHA: ≤10
Sigma-Aldrich
4-(二甲氨基)吡啶, ReagentPlus®, ≥99%
Sigma-Aldrich
N,N′-二环己基碳二亚胺, 99%
Sigma-Aldrich
二氯甲烷, puriss. p.a., ACS reagent, reag. ISO, ≥99.9% (GC)
Sigma-Aldrich
四氢呋喃, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%
Sigma-Aldrich
HEPES缓冲溶液, 1 M in H2O
Sigma-Aldrich
N,N-二甲基甲酰胺, for molecular biology, ≥99%
Sigma-Aldrich
三乙基胺, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
氯化氢 溶液, 2.0 M in diethyl ether
Sigma-Aldrich
邻苯二甲醛, ≥97% (HPLC), powder (may contain lumps)